NYSCF – Robertson Investigator Makes Progress in Genome Editing


NYSCF – Robertson Stem Cell Investigator Dr. Feng Zhang, Broad Institute of MIT and Harvard, published his latest work on genome editing in Nature Biotechnology. Dr. Zhang and his team showed how a targeted genome editing molecule structure called Cas9 works in mammalian cells. Further, this genome editing structure can be induced or dormant due to a split architecture that is activated by chemical induction.

This work to identify specific and targeted genome editing technologies will pave the way to future genetic based treatments.


Read the paper in Nature Biotechnology >>

Diseases & Conditions:

Genomics & Gene Editing

People mentioned: